Amirreza Azimi
-
- Multiple Sclerosis Research Studies 36
- Systemic Sclerosis and Related Diseases 7
- Vitamin D Research Studies 4
- Biochemistry top 5%
- Biological Psychiatry top 10%
- Neurology top 5%
- Peripheral Neuropathies and Disorders 5
- Amyotrophic Lateral Sclerosis Research 5
- Psychiatry and Mental health top 10%
- Fibromyalgia and Chronic Fatigue Syndrome Research 7
-
- SARS-CoV-2 and COVID-19 Research 5
-
- Coenzyme Q10 studies and effects 4
- Co-authors
- Mohammad Ali SahraianMohammad KhaliliMeisam SanoobarMahsa GhajarzadehAbdorreza Naser MoghadasiMehdi MohammadifarMahmood Reza GohariShima Jazayeri
- Journals
- SHILAP Revista de lepidopterología (2 papers)Neurology (1 paper)Vaccine (1 paper)
- Partner nations
- IranUnited StatesUnited Kingdom
In The Last Decade
Amirreza Azimi
60 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 108
- Pathology and Forensic Medicine 554
- Biochemistry 138
- Biological Psychiatry 45
- Neurology 215
- Psychiatry and Mental health 151
Countries citing papers authored by Amirreza Azimi
This map shows the geographic impact of Amirreza Azimi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amirreza Azimi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amirreza Azimi more than expected).
Fields of papers citing papers by Amirreza Azimi
This network shows the impact of papers produced by Amirreza Azimi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amirreza Azimi. The network helps show where Amirreza Azimi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Amirreza Azimi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 2 | |
| 2 | 2022 | 1 | |
| 3 | 2022 | 3 | |
| 4 | 2022 | 8 | |
| 5 | 2022 | 5 | |
| 6 | 2021 | 17 | |
| 7 | 2021 | 5 | |
| 8 | 2021 | 16 | |
| 9 | 2021 | 2 | |
| 10 | Bladder Dysfunction in Iranian Patients with Multiple Sclerosis | 2020 | 1 |
| 11 | 2020 | 9 | |
| 12 | 2020 | 7 | |
| 13 | 2019 | 5 | |
| 14 | 2019 | 6 | |
| 15 | 2018 | 1 | |
| 16 | 2018 | 16 | |
| 17 | 2018 | 10 | |
| 18 | 2017 | 9 | |
| 19 | 2014 | 51 | |
| 20 | 2013 | 85 |
About Amirreza Azimi
Amirreza Azimi is a scholar working on Pathology and Forensic Medicine, Neurology and Biochemistry, having authored 61 papers that have together received 1.1k indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (36 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (7 papers), Systemic Sclerosis and Related Diseases (7 papers), SARS-CoV-2 and COVID-19 Research (5 papers), Peripheral Neuropathies and Disorders (5 papers), Amyotrophic Lateral Sclerosis Research (5 papers), Coenzyme Q10 studies and effects (4 papers) and Vitamin D Research Studies (4 papers). The work is most often cited by research in Pathology and Forensic Medicine (554 citations), Biochemistry (138 citations) and Biological Psychiatry (45 citations). Amirreza Azimi has collaborated with scholars based in Iran, United States and United Kingdom. Frequent co-authors include Mohammad Ali Sahraian, Mohammad Khalili, Meisam Sanoobar, Mahsa Ghajarzadeh, Abdorreza Naser Moghadasi, Mehdi Mohammadifar, Mahmood Reza Gohari, Shima Jazayeri, Shahryar Eghtesadi and Ghazaleh Eskandari. Their work appears in journals such as SHILAP Revista de lepidopterología, Neurology and Vaccine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.